Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Operating Expenses | 562 | 329 | 229 | 131 | 621 |
| Operating Income | -562 | -329 | -229 | -131 | -621 |
| Other Income | 0 | 0 | -53 | 0 | 0 |
| Pre-tax Income | -562 | -329 | -282 | -131 | -621 |
| Net Income Continuous | -562 | -329 | -282 | -131 | -621 |
| Net Income | $-562 | $-329 | $-282 | $-131 | $-621 |
| EBITDA(a) | $-562 | $-329 | $-277 | $-130 | $-621 |